44:52

Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21

5:19

what is a nitrosamine? How is it formed?

1:22:14

Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs

36:41

Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.

11:54

MHRA || OOS Guideline ||

58:23

Carcinogenicity Assessment of Nitrosamines: Current Status

1:20:46

FDA Expectations on Controlling Nitrosamine Impurities in Human Drugs

57:15

Evaluation of Elemental Impurities in Drugs and Drug Products ICH Q3D(R2)